Detalhe da pesquisa
1.
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.
Blood
; 137(26): 3616-3628, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33763699
2.
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.
Am J Hematol
; 98(2): 264-271, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588407
3.
Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study.
Am J Hematol
; 94(6): 635-640, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30859608
4.
VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial.
Blood
; 127(21): 2569-74, 2016 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27002117
5.
Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.
Blood
; 128(25): 2941-2948, 2016 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27729323
6.
Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma.
Ann Hematol
; 97(5): 831-837, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29330561
7.
Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results.
Blood
; 125(9): 1411-7, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25575538
8.
Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?
Blood
; 126(25): 2713-9, 2015 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26516228
9.
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials.
Haematologica
; 98(1): 87-94, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875621
10.
Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.
Eur J Haematol
; 88(3): 249-59, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22023551
11.
Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial.
Haematologica
; 100(2): e56-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25398832
12.
Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma.
J Clin Oncol
; 37(19): 1657-1665, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31091136
13.
Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial.
Clin Cancer Res
; 25(14): 4224-4230, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31053600
14.
The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patients.
Medicine (Baltimore)
; 87(2): 99-109, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18344807
15.
Epoetin Beta once-weekly therapy in anemic patients with solid tumors and non-myeloid hematological malignancies receiving chemotherapy.
Oncology
; 74(1-2): 112-8, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18547966
16.
Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study.
Lancet Haematol
; 5(2): e82-e94, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29275118
17.
A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial.
Leukemia
; 32(6): 1404-1413, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29784907
18.
Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma.
Leukemia
; 36(3): 881-884, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34650225
19.
Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study.
Haematologica
; 91(8): 1027-32, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16885042
20.
Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial.
J Clin Oncol
; 34(30): 3609-3617, 2016 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27325857